Management and outcome of epistaxis under direct oral anticoagulants: a comparison with warfarin.

Thorsten SendMattis BertlichFritz HorlbeckDarius SchafighSaskia FreytagKlaus W EichhornIngo GräffFriedrich BootzMark Jakob

Published in: International forum of allergy & rhinology (2018)

We found no evidence to suggest epistaxis is more severe or requires more invasive therapy in patients given direct oral anticoagulants. A significant proportion of patients on vitamin K antagonists were not within the target range for international normalized ratio, highlighting one of the main issues with oral anticoagulation by vitamin K antagonists.

Keyphrases

direct oral anticoagulants
venous thromboembolism
atrial fibrillation
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
prognostic factors
early onset